A Canadian Study toward Changing Local Practice in the Diagnosis of Pediatric Celiac Disease

Table 1

Baseline and follow-up comparisons between diagnostic groups.

		Serological diagnosis; ()	Biopsy diagnosis; ()	value
Baseline	Age (years)^1	8.6 (3.5)	9.2 (3.5)	0.38
	Gender (M : F)	16 : 24	18 : 30	0.81
	Height -score^1	(1.04)	0.05 (0.99)	0.66
	Weight -score^1	(1.00)	0.04 (1.03)	0.73
	aTTG (U/mL)^2	595 (200–4100)	42 (7.8–2500)	<0.001
	GI symptoms	87.5%	85%	1.0
	Anemia/fatigue	65%	54%	0.38
	Symptoms
	Family history	47.5%	43%	0.67
		()	()
Follow-up	Diagnosis to follow-up (months)^1	11.0 (3.8)	11.7 (12.16)	0.42
	Age (years)^1	9.5 (3.5) ()	10.5 (3.7)	0.26
	Gender (M : F)	14 : 18	16 : 25	0.97
	Height -score^1	(1.04)	0.10 (1.00)	0.42
	Weight -score^1	(0.93)	0.10 (1.07)	0.37
	GFD adherence	94%	93%	0.43
	Symptom improvement	93%	85%	0.52
	aTTG (U/mL)^2	9.4 (1–98)	4.0 (1–420)	0.005
	% aTTG decline^2	98.5 (90.7–99.9)	91.4 (308–99.8)	<0.001
	aTTG < 7 U/mL%	40%	72%	0.013

Mean (standard deviation); median (range).